BWM
GILD icon

Bullock Wealth Management’s Gilead Sciences GILD Stock Holding History

Bullock Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$447K Buy
3,551
+1,355
+62% +$179K 0.19% 111
2026
Q1 		$308K Buy
2,196
+147
+7% +$20.6K 0.15% 126
2025
Q4 		$251K Buy
2,049
+2,020
+6,966% +$245K 0.12% 146
2025
Q3 		$3.25K Buy
+29
New +$3.3K ﹤0.01% 507

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bullock Wealth Management's GILD Position: Q2 2026 in Review

Bullock Wealth Management increased its Gilead Sciences (GILD) stake by 62% in Q2 2026, buying an estimated $179K and bringing the position to 3,551 shares worth $447K. The position accounts for 0.19% of the portfolio, ranked #111.

Bullock Wealth Management first reported a position in GILD in Q3 2025 and has held it in 4 quarters since. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Bullock Wealth Management held 3,551 shares of Gilead Sciences worth $447K as of Q2 2026.
  • Bullock Wealth Management bought 1,355 Gilead Sciences shares in Q2 2026, an estimated $179K.
  • Gilead Sciences made up 0.19% of Bullock Wealth Management's portfolio in Q2 2026, its #111 holding.
  • Bullock Wealth Management first reported a position in Gilead Sciences in Q3 2025 and has held it in 4 quarters since.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.